Since TNBC is ER/PR- and HER2-negative, common drugs used for breast cancer therapies such as tamoxifen; letrozole, which targets hormone receptors; and trastuzumab, which aims to destroy HER2 overexpression in breast cancer cells, are inapplicable in TNBC treatment. The gene discussed is NR4A1; the disease is breast cancer.